Cancer therapy developer Lava Therapeutics has raised $18.6m in a round featuring Merck Research Laboratories unit MRL Ventures.

NUI Galway's Neurent Medical has been backed by government investors WDC and Enterprise Ireland as it continues development on its rhinitis treatment device.

Nottingham spinout Locate Therapeutics is developing a polymer-based material that ensures stem cells and other therapies can be injected with precision.

Cancer therapy developer Lava Therapeutics has raised $18.6m in a round featuring Merck Research Laboratories unit MRL Ventures.

Fred Hutchinson Cancer Research Center is the third institution to gain an academic bridge program in collaboration with Evotec, with the latest instalment dubbed Lab591.

The EMS-backed gene therapy developer has filed for an $86.3m offering having raised about the same amount in venture funding.

BridgeBio Pharma retains a majority stake in spinoff Eidos, which has raised $91m in funding in just over a year.

Myriad Genetics will pay $375m in cash and stock for genetic screening provider Counsyl, allowing Illumina Ventures to exit.

InnovAllianz, an investment subsidiary of Allianz, has contributed to a $15m funding round for 3D organ printing company Biomodex.